{"DataElement":{"publicId":"2188150","version":"1","preferredName":"Medication Pain Administered Type","preferredDefinition":"the administered type of pain medication.","longName":"MEDS_PN_ADM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2013869","version":"4","preferredName":"Medication Pain","preferredDefinition":"information related to pain medication.","longName":"MEDS_PN","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177035","version":"1","preferredName":"Medication","preferredDefinition":"A drug or substance that treats or prevents or alleviates the symptoms of disease.","longName":"Medication","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A94-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177440","version":"1","preferredName":"Pain","preferredDefinition":"A feeling of distress, suffering, or agony caused by stimulation of specialized nerve endings. (OSM94)","longName":"Pain","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-5252-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E30AD7E8-4702-5C4F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"ISO compliance.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188149","version":"1","preferredName":"Medication Pain Administered Type","preferredDefinition":"the administered type of pain medication.","longName":"MEDS_PN_ADM_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Pill","valueDescription":"Pill","ValueMeaning":{"publicId":"2571780","version":"1","preferredName":"Pill","longName":"2571780","preferredDefinition":"Pill or tablet","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E571-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"CAMPBELB","dateModified":"2004-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E30AD7E8-471F-5C4F-E034-0003BA12F5E7","beginDate":"2004-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Liquid","valueDescription":"Liquid","ValueMeaning":{"publicId":"2567331","version":"1","preferredName":"Liquid","longName":"2567331","preferredDefinition":"A substance in the fluid state of matter having no fixed shape but a fixed volume.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liquid","conceptCode":"C45298","definition":"A substance in the fluid state of matter having no fixed shape but a fixed volume.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D410-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"MAESKEB","dateModified":"2022-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E30AD7E8-4722-5C4F-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Pump","valueDescription":"Pump","ValueMeaning":{"publicId":"2571781","version":"1","preferredName":"Pump","longName":"2571781","preferredDefinition":"drug-administration pump","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E572-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"CAMPBELB","dateModified":"2004-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E30AD7E8-4726-5C4F-E034-0003BA12F5E7","beginDate":"2004-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Patch","valueDescription":"Patch","ValueMeaning":{"publicId":"2571184","version":"1","preferredName":"Patch","longName":"2571184","preferredDefinition":"A drug delivery system that contains an adhesive backing and that permits its ingredients to diffuse from some portion of it (e.g., the backing itself, a reservoir, the adhesive, or some other component) into the body from the external site where it is applied.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patch Dosage Form","conceptCode":"C42968","definition":"A solid composed of an impermeable occlusive backing and a formulation matrix in which the active and/or inert ingredient(s) are dissolved or dispersed; possibly includes an adhesive layer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E31D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-07-23","modifiedBy":"MAESKEB","dateModified":"2013-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E30AD7E8-4729-5C4F-E034-0003BA12F5E7","beginDate":"2004-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Route of Administration","ValueMeaning":{"publicId":"3698078","version":"1","preferredName":"Other Route of Administration","longName":"3698078","preferredDefinition":"Route of drug administration not specified on this list.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Route of Administration","conceptCode":"C38290","definition":"Route of drug administration not specified on this list.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7F87591-0676-A535-E040-BB89AD437E5F","latestVersionIndicator":"Yes","beginDate":"2013-03-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF8C66C8-4BFD-8E0C-E040-BB89AD43498B","beginDate":"2014-01-09","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-01-09","modifiedBy":"ONEDATA","dateModified":"2014-01-09","deletedIndicator":"No"},{"value":"Oral","valueDescription":"Oral Route of Administration","ValueMeaning":{"publicId":"2581009","version":"1","preferredName":"Oral Route of Administration","longName":"2581009","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-097E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EF8C66C8-4C08-8E0C-E040-BB89AD43498B","beginDate":"2014-01-09","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-01-09","modifiedBy":"ONEDATA","dateModified":"2014-01-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"SWOG CRF:Southwest Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E30B094D-D5E4-5CD9-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"ZIEGLERK","dateModified":"2014-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"MEDS_PN_ADM_TP","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Medication type","type":"Preferred Question Text","description":"Medication type","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E30AEB08-A736-64DB-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-09-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-01","modifiedBy":"FORMBUILDER","dateModified":"2014-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}